Evidence in Allergy

👨‍🔬 Director: Dr. Derek Chu, MD PhD (@dkchu)
📋 Innovative clinical trials, guidelines, observational studies & knowledge translation
🏫 @McMasterU

[Evidence in Allergy @EvidenceAllergy]

Our new international study led by researchers at @MacDeptMed @HEI_McMaster @UofT_DoM identifies the most important risk factors for food allergy development, broadening our understanding of preventing food allergies.

https://t.co/r53IQbQEJF

[Evidence in Allergy @EvidenceAllergy]

Just published review of 2.8 million participants across 190 studies identifying the risk factors associated with the development of food allergies, published in @JAMAPediatrics.

Read here: https://t.co/bUJMOvALNv

[CTV News @CTVNews]

Babies given peanuts, fish, eggs early less likely to become allergic, study affirms https://t.co/UHDK1R4Bfr

[McMaster Health Sciences @machealthsci]

An international study led by researchers with @MacDeptMed have identified the most effective and safest treatments for chronic hives. @dkchu

https://t.co/s1tL0xQItY

[McMaster Health Sciences @machealthsci]

Asthma outcomes improve with inhaled corticosteroids plus formoterol, SABA, finds study.

Derek Chu (@dkchu), assistant professor @MacDeptMed, spoke with @GoHealio about the findings of the meta-analysis.

https://t.co/hCcmAa15rX

[JAMA @JAMA_current]

Combining inhaled corticosteroids (ICS) with short-acting beta-agonists (SABA) and combining ICS with formoterol were each associated with lower risks of severe asthma exacerbations, compared to SABA alone. #ACAAI24 https://t.co/DpBArguSsE

[Evidence in Allergy @EvidenceAllergy]

Do you use topical steroids to manage urticaria? See the evidence in our latest systematic review and meta-analysis, published in @AnnalsAllergy

https://t.co/ooKAemPDW2

[Evidence in Allergy @EvidenceAllergy]

Did you know that Evidence in Allergy is Canada's first @worldallergy Center of Excellence?

Our work advances our understanding in allergy, asthma, and clinical immunology

[Evidence in Allergy @EvidenceAllergy]

What are the comparative benefits and harms of all the topical and systemic treatments for atopic dermatitis? See @dkchu's recent interview with @GoHealio to learn all the details.

https://t.co/d13jvw5Iu1

[GlobalSkin @IADPO]

TODAY IS #WorldAtopicEczemaDay! #AtopicEczema is more than itchy skin, it is a systemic, multidimensional disease that affects the minds & bodies of people around the world - especially youth. https://t.co/cpCu7ZSzgo

#GlobalSkin #ShareTheBurden #IfYouOnlyKnew

[McMaster Health Sciences @machealthsci]

Findings from a recent review on topical therapy options for patients with atopic dermatitis (AD) have important and immediate implications for achieving optimal AD outcomes, says Derek Chu (@dkchu), assistant professor @MacDeptMed

https://t.co/5ET8fgL3Qw

[Evidence in Allergy @EvidenceAllergy]

Thank you to everyone for sharing their comments and feedback on our draft 2023 #AtopicDermatitis Practice Parameter Update. Read the final guideline soon in @AnnalsAllergy

The Joint Task Force on Practice Parameters is sponsored by the @AAAAI_org and @ACAAI

[Evidence in Allergy @EvidenceAllergy]

❕RESULTS❕ @dkchu and team compared patient-important outcomes among 68 treatments across 43,123 participants in 219 RCTs. These findings inform optimal #eczema management among patients, caregivers, and clinicians

[Evidence in Allergy @EvidenceAllergy]

🚨 Topical treatments are the mainstay for managing #AtopicDermatitis, but with so many options available, how do we choose the best one? Read the new #SystematicReview and network meta-analysis, now published in @jacionline

📄https://t.co/EYl0btwCZN

[Evidence in Allergy @EvidenceAllergy]

❗RESULTS❗@alexandro_chu and team compared patient-important outcomes among 75 treatments across 28,686 participants in 149 RCTs. These findings inform optimal #eczema management among patients, caregivers, and clinicians

[Evidence in Allergy @EvidenceAllergy]

📢NOW PUBLISHED📢 Discover the most effective and safest systemic treatments for #AtopicDermatitis. Read the latest #SystematicReview and network meta-analysis, now available in @jacionline

📃https://t.co/FGJsSmU0MZ

[National Eczema @nationaleczema]

Let’s step back in time to discover the major milestones in #eczema’s history and, perhaps, catch a glimpse of the future.

Learn more about eczema's origin story: https://t.co/HSATQ2UloH

#GetEczemaWise #atopicdermatitis #dermtwitter

[Evidence in Allergy @EvidenceAllergy]

We're studying new treatment options for people with tree nut #allergies. Have a tree nut allergy and want to learn more? Contact us: https://t.co/OXZ4qgNvJ7

[Evidence in Allergy @EvidenceAllergy]

#ICYMI Moderate-certainty evidence shows that topical calcineurin inhibitors do not increase cancer risk in patients with #eczema. Our findings support the safe use of tacrolimus and pimecrolimus. @LancetChildAdol https://t.co/8dG0FTJPrW

[Allergy & Asthma Network @AllergyAsthmaHQ]

#DYK that there are 7 different types of #eczema? Treatment options may vary depending on what type you have and it is important to understand the differences. Take a journey with us to guide you through the 7 types of eczema: https://t.co/25TY1UxmX1

[Evidence in Allergy @EvidenceAllergy]

We are partnering with @AAAAI_org & @ACAAI to develop an evidence-based, patient-centered guideline on severe asthma.

We are seeking patients & caregivers with lived experience to join our guideline group. If interested, please complete this interest form
https://t.co/v5TAttprxC